BridgeBio · 5 days ago
Senior Vice President, Market Access
San Francisco, CA
Full-time
Hybrid
Director/Executive
$435K/yr - $510K/yr
15+ years expBridgeBio is a pioneering biotech company focused on developing life-changing medicines for patients with unmet needs. They are seeking a Senior Vice President of Market Access to lead strategies that optimize patient access, reimbursement, and affordability for their U.S. portfolio, while collaborating with cross-functional teams to navigate the complexities of the healthcare environment.
BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Responsibilities
Lead, develop, and inspire a high-performing team, fostering an inclusive environment where people are empowered to do their best work in service of patients
Provide enterprise leadership on U.S. portfolio- and product-level pricing, access, reimbursement, distribution, HEOR and affordability strategies, spanning in-line products, lifecycle management, and future pipeline planning
Serve as a senior leader within the U.S. organization, contributing to both financial performance and long-term patient impact, and helping to shape BridgeBio’s commercial strategy as we grow
Partner closely with cross-functional stakeholders including Commercial, Medical Affairs, Legal, Finance, CMC, and Government Affairs to anticipate and respond to market, policy, and regulatory dynamics affecting patient access
Lead efforts to negotiate complex agreements across payers, PBMs, specialty and retail pharmacies, GPOs, and distribution partners
Build and oversee industry-leading patient and reimbursement support programs, leveraging technology, data, and human-centered design to reduce friction for patients, caregivers, and providers
Qualification
Required
Bachelor's degree in business, healthcare, or a related field
15+ years of experience within a pharmaceutical or biotechnology organization, with a demonstrated track record of building and leading high-impact teams and delivering meaningful business and patient outcomes
10+ years of direct leadership experience in U.S. Market Access, with exposure to complex portfolios including specialty and/or rare disease products
Deep understanding of the U.S. healthcare ecosystem, including payer, PBM, GPO, specialty pharmacy, distributor, and provider dynamics, and proven experience navigating challenging reimbursement and access scenarios
Established executive-level relationships with key U.S. access stakeholders and a reputation for credibility, transparency, and principled negotiation
Preferred
Advanced degree strongly preferred
Global or ex-U.S. experience is a plus
Benefits
401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
201-500 employees
H1B Sponsorship
BridgeBio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (5)
2023 (4)
2022 (4)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$4.9BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Debt Financing· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
Leadership Team
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
Neil Kumar
CEO and Founder
Recent News
BioWorld Financial Watch
2026-01-17
Company data provided by crunchbase